Jenna Abelli

President & Chief Executive Officer

2023 - Current

Advisory Board Member

2023

BioFab Startup Lab

Principal

2018

Anzu Partners is a venture capital and private equity firm that invests in breakthrough industrial technologies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. https://www.anzupartners.com/

Board Member

2021

CytoTronics is disrupting the traditional drug discovery process through a highly differentiated engineering approach. Spinning out from Harvard after a decade of research, our proprietary semiconductor-cell interface can deliver high-dimensional functional assessment of live-cell responses at scale. CytoTronics’ platform integrates the semiconductor-cell interface, live-cell biology, and machine learning, to generate more translational insights earlier in the drug discovery process, unlocking previously undruggable diseases.

Board Member

2022

BioFlyte® is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to our safety and security.

Senior Brand & Product Manager, Women's Lacrosse

2014 - 2018

Project Leader Tire Line Development

2010 - 2014

Advanced Development Programs

2010 - 2013

Market Development in MENA (Hannover, Germany) Parts Complexity Reduction in Manufacturing (Lousado, Portugal) eXplore R&D Program (Hannover, Germany)

Physical Science Technician

2009 - 2010